Copyright Reports & Markets. All rights reserved.

Global P2X7 Receptor Antagonists Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global P2X7 Receptor Antagonists Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 GSK1482160
      • 1.4.3 AZD9056
      • 1.4.4 EVT 401
      • 1.4.5 JNJ 55308942 & JNJ 54175446
      • 1.4.6 AKP-23494954/RQ-00466479
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global P2X7 Receptor Antagonists Market Share by Application (2014-2025)
      • 1.5.2 Inflammatory Diseases
      • 1.5.3 Central Nervous System Diseases
      • 1.5.4 Immune System Disorders
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 P2X7 Receptor Antagonists Market Size
    • 2.2 P2X7 Receptor Antagonists Growth Trends by Regions
      • 2.2.1 P2X7 Receptor Antagonists Market Size by Regions (2014-2025)
      • 2.2.2 P2X7 Receptor Antagonists Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 P2X7 Receptor Antagonists Market Size by by Players
      • 3.1.1 Global P2X7 Receptor Antagonists Revenue by by Players (2014-2019)
      • 3.1.2 Global P2X7 Receptor Antagonists Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global P2X7 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
    • 3.2 P2X7 Receptor Antagonists Key Players Head office and Area Served
    • 3.3 Key Players P2X7 Receptor Antagonists Product/Solution/Service
    • 3.4 Date of Enter into P2X7 Receptor Antagonists Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global P2X7 Receptor Antagonists Market Size by Type (2014-2019)
    • 4.2 Global P2X7 Receptor Antagonists Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States P2X7 Receptor Antagonists Market Size (2014-2019)
    • 5.2 P2X7 Receptor Antagonists Key Players in United States
    • 5.3 United States P2X7 Receptor Antagonists Market Size by Type
    • 5.4 United States P2X7 Receptor Antagonists Market Size by Application

    6 Europe

    • 6.1 Europe P2X7 Receptor Antagonists Market Size (2014-2019)
    • 6.2 P2X7 Receptor Antagonists Key Players in Europe
    • 6.3 Europe P2X7 Receptor Antagonists Market Size by Type
    • 6.4 Europe P2X7 Receptor Antagonists Market Size by Application

    7 China

    • 7.1 China P2X7 Receptor Antagonists Market Size (2014-2019)
    • 7.2 P2X7 Receptor Antagonists Key Players in China
    • 7.3 China P2X7 Receptor Antagonists Market Size by Type
    • 7.4 China P2X7 Receptor Antagonists Market Size by Application

    8 Japan

    • 8.1 Japan P2X7 Receptor Antagonists Market Size (2014-2019)
    • 8.2 P2X7 Receptor Antagonists Key Players in Japan
    • 8.3 Japan P2X7 Receptor Antagonists Market Size by Type
    • 8.4 Japan P2X7 Receptor Antagonists Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia P2X7 Receptor Antagonists Market Size (2014-2019)
    • 9.2 P2X7 Receptor Antagonists Key Players in Southeast Asia
    • 9.3 Southeast Asia P2X7 Receptor Antagonists Market Size by Type
    • 9.4 Southeast Asia P2X7 Receptor Antagonists Market Size by Application

    10 India

    • 10.1 India P2X7 Receptor Antagonists Market Size (2014-2019)
    • 10.2 P2X7 Receptor Antagonists Key Players in India
    • 10.3 India P2X7 Receptor Antagonists Market Size by Type
    • 10.4 India P2X7 Receptor Antagonists Market Size by Application

    11 Central & South America

    • 11.1 Central & South America P2X7 Receptor Antagonists Market Size (2014-2019)
    • 11.2 P2X7 Receptor Antagonists Key Players in Central & South America
    • 11.3 Central & South America P2X7 Receptor Antagonists Market Size by Type
    • 11.4 Central & South America P2X7 Receptor Antagonists Market Size by Application

    12 International Players Profiles

    • 12.1 GlaxoSmithKline
      • 12.1.1 GlaxoSmithKline Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 P2X7 Receptor Antagonists Introduction
      • 12.1.4 GlaxoSmithKline Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.1.5 GlaxoSmithKline Recent Development
    • 12.2 AstraZeneca
      • 12.2.1 AstraZeneca Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 P2X7 Receptor Antagonists Introduction
      • 12.2.4 AstraZeneca Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.2.5 AstraZeneca Recent Development
    • 12.3 Janssen
      • 12.3.1 Janssen Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 P2X7 Receptor Antagonists Introduction
      • 12.3.4 Janssen Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.3.5 Janssen Recent Development
    • 12.4 RaQualia Pharma
      • 12.4.1 RaQualia Pharma Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 P2X7 Receptor Antagonists Introduction
      • 12.4.4 RaQualia Pharma Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.4.5 RaQualia Pharma Recent Development
    • 12.5 Evotec
      • 12.5.1 Evotec Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 P2X7 Receptor Antagonists Introduction
      • 12.5.4 Evotec Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.5.5 Evotec Recent Development
    • 12.6 Asahi Kasei Pharma
      • 12.6.1 Asahi Kasei Pharma Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 P2X7 Receptor Antagonists Introduction
      • 12.6.4 Asahi Kasei Pharma Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.6.5 Asahi Kasei Pharma Recent Development
    • 12.7 Pfizer
      • 12.7.1 Pfizer Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 P2X7 Receptor Antagonists Introduction
      • 12.7.4 Pfizer Revenue in P2X7 Receptor Antagonists Business (2014-2019)
      • 12.7.5 Pfizer Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      P2X7 Receptor (P2X7R) is an ATP-gated ion channel primarily expressed on cells of the immune system and is thought to play an important role in inflammatory processes through the regulation of a number of proinflammatory cytokines. P2X7 Receptor Antagonists can provide a novel approach to the treatment of rheumatoid arthritis and other inflammatory diseases. Moreover, P2X7 receptors have been proposed to be potential therapeutic target sites in disorders of the nervous system, such as ischemia-reperfusion injury, Alzheimer's disease, spinal cord injury and neuropathic pain.
      In 2018, the global P2X7 Receptor Antagonists market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global P2X7 Receptor Antagonists status, future forecast, growth opportunity, key market and key players. The study objectives are to present the P2X7 Receptor Antagonists development in United States, Europe and China.

      The key players covered in this study
      GlaxoSmithKline
      AstraZeneca
      Janssen
      RaQualia Pharma
      Evotec
      Asahi Kasei Pharma
      Pfizer
      ...

      Market segment by Type, the product can be split into
      GSK1482160
      AZD9056
      EVT 401
      JNJ 55308942 & JNJ 54175446
      AKP-23494954/RQ-00466479
      Others

      Market segment by Application, split into
      Inflammatory Diseases
      Central Nervous System Diseases
      Immune System Disorders

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global P2X7 Receptor Antagonists status, future forecast, growth opportunity, key market and key players.
      To present the P2X7 Receptor Antagonists development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of P2X7 Receptor Antagonists are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now